title: Prevention of respiratory syncytial virus (RSV) infection: RSV immune globulin intravenous and palivizumab. (American Academy of Pediatrics).
authors.affiliation: Section of Infectious Diseases, University of Colorado Health Sciences Center, Denver, USA.
authors.forename: S D
authors.initials: SD
authors.lastname: Canfield
authors.forename: E A
authors.initials: EA
authors.lastname: Simoes
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000276:immunology; D061067:Antibodies, Monoclonal, Humanized; D002648:Child; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage*; D007275:Injections, Intravenous; D008297:Male; D000069455:Palivizumab; D018357:Respiratory Syncytial Virus Infections / Q000276:immunology / Q000517:prevention & control*; D018113:Respiratory Syncytial Virus, Human / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007136:Immunoglobulins; D000069455:Palivizumab